The Diabetes Center Mergentheim is a large and modern treatment center for people with diabetes mellitus in Germany. The center includes the Diabetes-Clinic, the Diabetes-Academy, FIDAM, the Diabetes-Medical Practice, ConDiaZ and InsulinJA.

There are 155 (2011) beds in Diabetes Zentrum Mergentheim.

During the past decade, Diabetes Zentrum Mergentheim conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diabetes Zentrum Mergentheim" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Diabetes Zentrum Mergentheim" are "Type 1 Diabetes" (2 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Diabetes Zentrum Mergentheim" in a lesser frequency.

Most popular intervention types in "Diabetes Zentrum Mergentheim" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin" (1 trials), "FreeStyle Freedom Lite" (1 trials), "FreeStyle InsuLinx" (1 trials), "Sensor Based Glucose Monitoring System" (1 trials) and "Standard Blood Glucose Monitoring" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diabetes Zentrum Mergentheim" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Diabetes Zentrum Mergentheim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Diabetes Zentrum Mergentheim, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Diabetes Zentrum Mergentheim, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".